RANI THERAPEUTICS HOLDINGS, INC. Research and Development Expense
RANI THERAPEUTICS HOLDINGS, INC. (RANI) reported Research and Development Expense of $5.02 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-13
- RANI THERAPEUTICS HOLDINGS, INC. research and development expense for the quarter ending 2026-06-30 was $5.02M, a 8.86% decline year-over-year.
- RANI THERAPEUTICS HOLDINGS, INC. research and development expense for the quarter ending 2026-03-31 was $5.16M, a 21.45% decline year-over-year.
- RANI THERAPEUTICS HOLDINGS, INC. research and development expense for the quarter ending 2025-12-31 was $4.91M, a 27.91% decline year-over-year.
- RANI THERAPEUTICS HOLDINGS, INC. research and development expense for the quarter ending 2025-09-30 was $3.22M, a 47.81% decline year-over-year.
- RANI THERAPEUTICS HOLDINGS, INC. research and development expense for fiscal 2025 was $20.20M, a 24.27% decline from fiscal 2024.
- RANI THERAPEUTICS HOLDINGS, INC. research and development expense for fiscal 2024 was $26.68M, a 32.66% decline from fiscal 2023.
- RANI THERAPEUTICS HOLDINGS, INC. research and development expense for fiscal 2023 was $39.62M, a 8.24% increase from fiscal 2022.
- RANI THERAPEUTICS HOLDINGS, INC. research and development expense for fiscal 2022 was $36.61M, a 38.23% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.02M 10-Q · filed 2026-08-13 | $10.18M 10-Q · filed 2026-08-13 | $15.09M derived: sum of 3 quarters · filed 2026-08-13 | $18.31M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $5.16M 10-Q · filed 2026-05-15 | $10.07M derived: sum of 2 quarters · filed 2026-05-15 | $13.29M derived: sum of 3 quarters · filed 2026-05-15 | $18.80M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $4.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $8.13M derived: sum of 2 quarters · filed 2026-03-26 | $13.63M derived: sum of 3 quarters · filed 2026-08-13 | $20.20M 10-K · filed 2026-03-26 |
| 2025-09-30 | $3.22M 10-Q · filed 2025-11-06 | $8.73M derived: sum of 2 quarters · filed 2026-08-13 | $15.30M 10-Q · filed 2025-11-06 | $22.11M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $5.50M 10-Q · filed 2026-08-13 | $12.07M 10-Q · filed 2026-08-13 | $18.89M derived: sum of 3 quarters · filed 2026-08-13 | $25.06M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $6.57M 10-Q · filed 2026-05-15 | $13.38M derived: sum of 2 quarters · filed 2026-05-15 | $19.55M derived: sum of 3 quarters · filed 2026-05-15 | $25.67M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $6.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $12.98M derived: sum of 2 quarters · filed 2026-03-26 | $19.10M derived: sum of 3 quarters · filed 2026-03-26 | $26.68M 10-K · filed 2026-03-26 |
| 2024-09-30 | $6.17M 10-Q · filed 2025-11-06 | $12.29M derived: sum of 2 quarters · filed 2025-11-06 | $19.87M 10-Q · filed 2025-11-06 | $27.48M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $6.12M 10-Q · filed 2025-08-07 | $13.70M 10-Q · filed 2025-08-07 | $21.31M derived: sum of 3 quarters · filed 2025-08-07 | $32.53M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $7.59M 10-Q · filed 2025-05-13 | $15.19M derived: sum of 2 quarters · filed 2025-05-13 | $26.41M derived: sum of 3 quarters · filed 2025-05-13 | $37.50M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $7.61M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $18.83M derived: sum of 2 quarters · filed 2025-03-31 | $29.91M derived: sum of 3 quarters · filed 2025-03-31 | $39.62M 10-K · filed 2025-03-31 |
| 2023-09-30 | $11.22M 10-Q · filed 2024-11-14 | $22.31M derived: sum of 2 quarters · filed 2024-11-14 | $32.02M 10-Q · filed 2024-11-14 | $42.40M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $11.09M 10-Q · filed 2024-08-06 | $20.80M 10-Q · filed 2024-08-06 | $31.18M derived: sum of 3 quarters · filed 2024-08-06 | $40.29M derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $9.71M 10-Q · filed 2024-05-06 | $20.10M derived: sum of 2 quarters · filed 2024-05-06 | $29.20M derived: sum of 3 quarters · filed 2024-05-06 | $38.73M derived: sum of 4 quarters · filed 2024-05-06 |
| 2022-12-31 | $10.39M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $19.49M derived: sum of 2 quarters · filed 2024-03-20 | $29.02M derived: sum of 3 quarters · filed 2024-03-20 | $36.61M 10-K · filed 2024-03-20 |
| 2022-09-30 | $9.10M 10-Q · filed 2023-11-08 | $18.63M derived: sum of 2 quarters · filed 2023-11-08 | $26.22M 10-Q · filed 2023-11-08 | $33.64M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $9.53M 10-Q · filed 2023-08-11 | $17.12M 10-Q · filed 2023-08-11 | $24.54M derived: sum of 3 quarters · filed 2023-08-11 | $36.49M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $7.59M 10-Q · filed 2023-05-10 | $15.01M derived: sum of 2 quarters · filed 2023-05-10 | $26.97M derived: sum of 3 quarters · filed 2023-05-10 | $30.73M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $7.42M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $19.38M derived: sum of 2 quarters · filed 2023-03-22 | $23.14M derived: sum of 3 quarters · filed 2023-03-22 | $26.48M 10-K · filed 2023-03-22 |
| 2021-09-30 | $11.96M 10-Q · filed 2022-11-10 | $15.72M derived: sum of 2 quarters · filed 2022-11-10 | $19.07M 10-Q · filed 2022-11-10 | $22.40M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $3.76M 10-Q · filed 2022-08-10 | $7.11M 10-Q · filed 2022-08-10 | $10.44M derived: sum of 3 quarters · filed 2022-08-10 | $12.53M derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $3.35M 10-Q · filed 2022-05-11 | $6.68M derived: sum of 2 quarters · filed 2022-05-11 | $8.77M derived: sum of 3 quarters · filed 2022-05-11 | $11.33M derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | $3.34M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $5.43M derived: sum of 2 quarters · filed 2022-03-31 | $7.98M derived: sum of 3 quarters · filed 2022-03-31 | $12.04M 10-K · filed 2022-03-31 |
| 2020-09-30 | $2.09M 10-Q · filed 2021-11-16 | $4.65M derived: sum of 2 quarters · filed 2021-11-16 | $8.71M 10-Q · filed 2021-11-16 | |
| 2020-06-30 | $2.56M 10-Q · filed 2021-09-13 | $6.62M 10-Q · filed 2021-09-13 |